NASDAQ:ACRS | EBITDA Margin | Aclaris Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-1106.71%
2025-12-31-1747.64%
2025-03-31-1234.09%
2024-12-31-1080.58%
2024-03-31-779.32%
2023-12-31-21.74%
2023-03-31-1175.63%
2022-12-31-372.62%
2022-03-31-1286.92%
2021-12-31-1512.06%
2021-03-31-1589.25%
2020-12-31-886.65%
2020-03-31-1061.12%
2019-12-31-1573.79%
2019-03-31-1965.56%
2018-12-31-1302.82%
2018-03-31-2748.30%
2017-12-31-720.62%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-970.11%
2024-12-31-753.87%
2023-12-31-308.79%
2022-12-31-299.33%
2021-12-31-1313.42%
2020-12-31-765.01%
2019-12-31-2475.73%
2018-12-31-1347.76%
2017-12-31-3206.12%